What amount sold does Avitide, Inc. report in Form D filings?

The latest linked filings report $40.9M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Avitide, Inc.'s most recent SEC filing?

Avitide, Inc.'s most recent Form D filing was on 2019-10-23.

How many investors does Avitide, Inc. have?

The most recent Form D filing lists 9 investor(s).

What type of securities does Avitide, Inc. offer?

Avitide, Inc.'s SEC Form D filings indicate equity offerings.

Avitide, Inc.

CIK: 0001571506·Biotechnology·LEBANON, NH·Corporation

Reported Sold

$40,928,953

Total Filings

Identified Offerings

Last Filed

Oct 23, 2019

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 23, 2019Form D — New notice

Reported sold: $9,999,796 · Target: $9,999,796

Rule 506(b)·9 investors

Aug 24, 2018Form D — New notice

Reported sold: $6,212,290 · Target: $6,212,290

Rule 506(b)·4 investors

Jan 2, 2018Form D — New notice

Reported sold: $3,999,983 · Target: $3,999,983

Rule 506(b)·3 investors

Jun 27, 2017Form D — New notice

Reported sold: $11,999,962 · Target: $11,999,962

Rule 506(b)·10 investors

Aug 6, 2015Form D — New notice

Reported sold: $3,831,920 · Target: $7,663,840

Rule 506(b)·11 investors

Jun 9, 2014Form D — New notice

Reported sold: $3,435,003 · Target: $3,435,003

Rule 506(b)·7 investors

Mar 15, 2013Form D — New notice

Reported sold: $1,449,999 · Target: $1,449,999

Rule 506·7 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 7 identified offerings

$40,928,953

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Rishi Gupta

Related Person

Appears on 6 filings

Philip Ferneau

Related Person

Appears on 6 filings

Claudio Nessi

Related Person

Appears on 5 filings

Tillman Gerngross

Related Person

Appears on 5 filings

Kevin Isett

Related Person

Appears on 5 filings

Ian Ratcliffe

Related Person

Appears on 4 filings

Warren Kett

Related Person

Appears on 4 filings

Scott Kennedy

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 23, 2019	New	$9,999,796	$9,999,796	9
Aug 24, 2018	New	$6,212,290	$6,212,290	4
Jan 2, 2018	New	$3,999,983	$3,999,983	3
Jun 27, 2017	New	$11,999,962	$11,999,962	10
Aug 6, 2015	New	$7,663,840	$3,831,920	11
Jun 9, 2014	New	$3,435,003	$3,435,003	7
Mar 15, 2013	New	$1,449,999	$1,449,999	7

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AdhereBio LLC

Biotechnology

Offering target: $5,000,000

Filed Oct 26, 2026